NeuroPace (NPCE) Reports In-Line Q1 EPS, provides guidance

NeuroPace (NASDAQ: NPCE) reported Q1 EPS of ($0.32), in-line with the analyst estimate of ($0.32). Revenue for the quarter came in at $18.1 million versus the consensus estimate of $17.33 million.

GUIDANCE:

NeuroPace sees FY2024 revenue of $73-77 million, versus the consensus of $75.209 million.
Gross margin to range between 72% and 74%
Total operating expenses to range between $80 million and $84 million, including approximately $12 million in stock-based compensation, a noncash expense

For earnings history and earnings-related data on NeuroPace (NPCE) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c